In the first scenario, all MCNs may initially arise through KRAS-independent molecular events (e.g., low-frequency alterations found in LG cysts like CRTC1 and PTCH1) and only subsequently acquire an activating mutation in KRAS and a more aggressive behavior. The gene discussed is KRAS; the disease is lipoid nephrosis.